期刊文献+

游离轻链检测对多发性骨髓瘤诊断的临床意义 被引量:10

Clinical Significance of Free Light Chain Tests for Multiple Myeloma Diagnosis
下载PDF
导出
摘要 目的评价免疫固定电泳、尿液轻链定量及血清游离轻链检测在多发性骨髓瘤(MM)患者轻链检测中的价值。方法用速率散射比浊法进行重链、轻链及游离轻链定量,用蛋白电泳及免疫固定电泳法对M成份做定性分析,对多发性骨髓瘤患者轻链型21例,完整型29例(其中IgGI、gA型19例;IgD型10例)标本分别做免疫固定电泳,尿轻链定量及游离轻链检测,然后比较三种方法的检出率和灵敏度。结果对于轻链型骨髓瘤患者,免疫固定电泳、尿轻链定量及血清游离轻链检测三种方法的轻链检测阳性率分别为90.5%(19/21);80.9%(17/21);100%(21/21)。对于完整型骨髓瘤患者三种方法的游离轻链检测(免疫固定电泳法检测与重链结合的单克隆轻链的阳性率100%)阳性率分别为20.7%(6/29);41.4%(12/29);82.7%(24/29)。结论血清游离轻链检测较另外两种方法检测游离轻链更为灵敏,其与免疫固定电泳法结合检测对多发性骨髓瘤患者的明确诊断、疗效观察及改善预后起重要作用。 Objective Evaluation of the tests of Immunofixation Electrophoresis(IFE),urine light chain quantitive analysis and serum free light chain immunoassay for measurement of free light chain in multiple myeloma patients.Methods Turbidimetric method was used to quantify heavy chains,and total light chains(free and combined light chains),protein electrophoresis(PE) and IFE were used to identify and type the M proteins in 21 light chain multiple myeloma(LCMM)and 29 intact immunoglobulin multiple myeloma(IIMM)patients;.Detection rate and accuracy of the three kinds of tests were compared.Results In LCMM patients,the detection rate for immunofixation Electrophoresis,urine light chain quantitive analysis and serum free light chain immunoassay were 90.5 %(19/21);80.9 %(17/21);100%(21/21)and were20.7 %(6/29);41.4 %(12/29);82.7 %(24/29)in IIMM patients,and all the combining monoclonal light chains were detected by IFE.Conclusion Serum free light chain immunoassay was more sensitive than the other two,if combining with IFE,they will help to diagnose,monitor and improve prognosis of multiple myeloma patients.
出处 《中国实验诊断学》 北大核心 2011年第9期1525-1527,共3页 Chinese Journal of Laboratory Diagnosis
关键词 多发性骨髓瘤 游离轻链 免疫固定电泳 multiple myeloma free light chain immunofixation electrophoresis
  • 相关文献

参考文献6

  • 1梁玉芳,陈文明,王清涛.血清游离轻链检测及其临床应用[J].中华检验医学杂志,2007,30(11):1298-1300. 被引量:6
  • 2Kang SY,Suh JT,Lee HJ,et al.Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma[J].Ann Hematol,2005,84:588. 被引量:1
  • 3Bradwell AR,Carr-Smith HD,Mead GP,et al.Serum test for assessment of patients with Bence Jones myeloma[J].Lancet,2003,361:489. 被引量:1
  • 4Nowrousian MR,Brandhorst D,Sammet C,et al.Serum analysis and urine immunofixation electrophoresis in patients with multiple myeloma[J].Clin Cancer Res,2005,11:8706. 被引量:1
  • 5Mead GP,Carr-Smith HD,Drayson MT,et al.Serum free light chain for monitoring multiple myeloma[J].Br J Haematol,2004,126:348. 被引量:1
  • 6Bradwell AR,Carr-Smith HD,Mead GP,et al.Highly sensitive,automated immunoassay for immunoglobulin free light chain in Serum and urine[J].Clin Chem,2001,47:673. 被引量:1

二级参考文献20

  • 1Bradwell AR, Cart-Smith HD, Mead GP, et al. Serum free light chain immunoassays and their clinical application. Clin Appl Immunol Rev, 2002,3 : 17-33. 被引量:1
  • 2Vander MH, Kraneveld A, Redegeld F. Free immunoglobulin light chains as target in the treatment of chronic inflammatory diseases. Eur J Phar, 2006,533:319-326. 被引量:1
  • 3Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem, 2002,48:1437-1444. 被引量:1
  • 4Mead GP, Cart-Smith HD, Drayson MT, et al. Serum free light chains for monitoring multiple myeloma. Br J Haematol, 2004, 126:348-354. 被引量:1
  • 5Kang SY, Suh JT, Lee HJ, et al. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Ann Hematol, 2005,84:588-593. 被引量:1
  • 6Jaskowski TD, Litwin CM, Hill HR. Detection of κ and λ light chain monoclonal protein in human serum:automated immunoassay versus immunofixation electrophoresis. Clin Vac Immun, 2006, 13:277-280. 被引量:1
  • 7Graziani M, Merlini G, Petrini C. Guidelines for the analysis of bence jones protein. Clin Chem Lab Med, 2003,413:338-346. 被引量:1
  • 8Herzum I, Renz H, Wahl HG. Immunochemlcal quantification of free light chains in urine. Clin Chem, 2005,51:1033-1035. 被引量:1
  • 9Bradwell AR, Carr-Smith HD, Mead GP, et al. Serum test for assessment of patients with Bence Jones myeloma. Lancet, 2003, 361 : 489-491. 被引量:1
  • 10Nowrousian MR, Brandhorst D, Sammet C, et al. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma. Clin Cancer Res, 2005, 11 (24 pt1 ) :8706-8714. 被引量:1

共引文献5

同被引文献62

  • 1张骏,邓宏宇,巫刚.多发性骨髓瘤患者血钙异常的临床分析[J].中华血液学杂志,2005,26(4):246-247. 被引量:20
  • 2邹小立,佘妙容,黄梓伦,林伟.28例多发性骨髓瘤免疫分型及临床分析[J].实用医学杂志,1996,12(5):290-291. 被引量:9
  • 3翟玉华.轻链型多发性骨髓瘤免疫分型及意义[J].现代检验医学杂志,2007,22(1):22-23. 被引量:9
  • 4许文荣,王建中.临床血液学与检验[M].4版.北京:人民卫生出版社,2008:259. 被引量:16
  • 5Bradwell AR, Cart- Smith HD, Mead GP, et al. Serum test for as- sessment of patients with Bence Jones myeloma [ J ]. The Lancet, 2003, 361 (9356) : 489 -491. 被引量:1
  • 6Durie BGM, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma [ J ]. Leukemia, 2006, 20 (9) : 1467 -1473. 被引量:1
  • 7Lahuerta J J, Martinez-Lopez J, Serna J, et al. Remission status de- fined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients[J]. Br J Haematol, 2000,109 (2) : 438-446. 被引量:1
  • 8Bradwell AR, Carr - smith HD, Mead GP, et al. Serum test for as- sessment of patients with Bence Jones myeloma[ J]. Lancet, 2003, 361 (9356).: 489 -491. 被引量:1
  • 9Mangiacavalli S, Pochintesta L, Pascutto C, et al. Good clinical activity and favorable toxicity profile of once weekly bortezomib, fotemustine, and dexamethasone ( B - MuD) for the treatment of re- lapsed muhiple myeloma [ J ]. Am J Hematol, 2013, 88 ( 2 ) : 102 - 106. 被引量:1
  • 10Wertz N, Vazquez J, Wells K, et al. Antibody repertoire develop- ment in fetal and neonatal piglets. XII. Three IGLV genes comprise 70% of the pre - immune repertoire and there is little junctional di- versity[J]. Mol Immunol, 2013, 55(3) : 319-328. 被引量:1

引证文献10

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部